Suppr超能文献

价格透明度的实施:CMS 指令后医院收费主文件的可及性和医院定价的变化。

Price transparency implementation: Accessibility of hospital chargemasters and variation in hospital pricing after CMS mandate.

机构信息

Yale School of Medicine, New Haven, CT, USA; Eastern Connecticut Health Network, Manchester, CT, USA.

Yale School of Medicine, New Haven, CT, USA.

出版信息

Healthc (Amst). 2020 Sep;8(3):100443. doi: 10.1016/j.hjdsi.2020.100443. Epub 2020 Jul 4.

Abstract

BACKGROUND

National regulations have increasingly focused on transparency in hospital billing and pricing practices. A January 2019 federal mandate required hospitals to publicize lists of billable procedures and items known as chargemasters.

METHODS

We identified the 500 top self-pay/uninsured revenue grossing hospitals nationally and searched each hospital's website for a chargemaster. Corresponding items were matched across chargemasters. Intrahospital and interhospital price variation were calculated. To investigate variation in item naming, a name variant and fuzzy matching search was conducted for fifteen common chargemaster items.

RESULTS

Of 500 hospitals in this study, 69 (13.8%) had chargemasters that were inaccessible and 30 (6.0%) had chargemasters that did not meet mandated requirements. Among the remaining 431 hospitals, the mean interhospital and intrahospital variation in pricing for identical items was 18% (SD 28%) and 28% (SD 29%), respectively. 388 hospitals listed multiple prices for the same item, with a mean of 687.3 duplicated items (SD 1157.7). Among fifteen common chargemaster items, each item was associated with an average of 275 (SD 213) unique name variants. Interhospital price variation of these items ranged from 53% (transthoracic echocardiogram) to 243% (furosemide 40 mg).

CONCLUSIONS

Many chargemasters have barriers to access, and item naming is inconsistent across chargemasters. There is significant interhospital price variation for similar items.

IMPLICATIONS

Chargemasters are uninterpretable for the purpose of patient price comparison in their current form. Further regulatory efforts are necessary to increase price transparency and enhance the ability of patients to compare hospital prices.

摘要

背景

国家法规越来越关注医院计费和定价实践的透明度。2019 年 1 月的一项联邦命令要求医院公布所谓的计费主文件中可计费的程序和项目清单。

方法

我们确定了全国 500 家自负盈亏/无保险收入最高的医院,并在每家医院的网站上搜索计费主文件。在计费主文件中匹配相应的项目。计算了医院内和医院间的价格差异。为了调查项目命名的差异,对 15 个常见的计费主文件项目进行了名称变体和模糊匹配搜索。

结果

在这项研究的 500 家医院中,有 69 家(13.8%)的计费主文件无法访问,有 30 家(6.0%)的计费主文件不符合规定要求。在其余的 431 家医院中,相同项目的医院间和医院内定价差异分别为 18%(SD 28%)和 28%(SD 29%)。388 家医院对同一项目列出了多个价格,平均有 687.3 个重复项目(SD 1157.7)。在 15 个常见的计费主文件项目中,每个项目平均有 275 个(SD 213)独特的名称变体。这些项目的医院间价格差异范围为 53%(经胸超声心动图)至 243%(呋塞米 40mg)。

结论

许多计费主文件难以访问,并且项目命名在计费主文件之间不一致。类似项目的医院间价格差异很大。

意义

计费主文件以其目前的形式对于患者的价格比较是不可理解的。需要进一步的监管努力来提高价格透明度,并增强患者比较医院价格的能力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验